List of works - Christian Möbs

6th International Symposium on Molecular Allergology (ISMA).

scientific article

7th Drug hypersensitivity meeting: part two.

scientific article

Allergen immunotherapy with the hypoallergenic B-cell epitope-based vaccine BM32 modifies IL-10- and IL-5-secreting T cells

scientific article published on 29 August 2019

Birch pollen allergen-specific immunotherapy with glutaraldehyde-modified allergoid induces IL-10 secretion and protective antibody responses

scientific article published on 11 April 2019

Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation

scientific article published on 04 January 2010

Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies

scientific article published on 27 September 2012

Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.

scientific article published on 21 November 2017

CD3-positive B cells: a storage-dependent phenomenon

scientific article

Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.

scientific article published on 02 July 2008

Cellular in vitro diagnosis of adverse drug reactions

scientific article published on 07 August 2014

Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris

scientific article published on 01 April 2012

Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy

scientific article published on 28 March 2015

Diagnostics of drug hypersensitivity reactions

scientific article

Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.

scientific article published on 5 June 2017

IgE and allergen-specific immunotherapy-induced IgG4 recognize similar epitopes of Bet v 1, the major allergen of birch pollen.

scientific article published on 22 October 2016

Immunoglobulin E and G4 epitopes of the major allergen of birch pollen Bet v 1 share residues critical for antibody binding.

scientific article published on 25 July 2013

Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects.

scientific article published on 23 November 2017

Influenza-derived peptides cross-react with allergens and provide asthma protection.

scientific article published on 10 November 2017

Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.

scientific article published on 21 September 2013

Monitoring the epitope recognition profiles of IgE, IgG 1 , and IgG 4 during birch pollen immunotherapy

scientific article published on 10 December 2015

Predominance of IL-5-secreting drug-specific T cells in subgroups of patients with drug-induced delayed-type hypersensitivity reaction

scientific article

Research Techniques Made Simple: Monitoring of T-Cell Subsets using the ELISPOT Assay.

scientific article published on June 2016

Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions.

scientific article published on 17 July 2017

Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner.

scientific article published on 25 December 2013

Structure of intact IgE and the mechanism of ligelizumab revealed by electron microscopy

scientific article published on 09 February 2020

T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita

scientific article published on 25 January 2010

The diversity of Bet v 1–specific IgG 4 antibodies remains mostly constant during the course of birch pollen immunotherapy

scientific article published on 02 July 2015

The honey bee venom allergen Api m 10 displays one major IgE epitope, Api m 10160-174

scientific article published on 20 January 2020

Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.

scientific article published on 2 January 2018

List of works by Christian Möbs

6th International Symposium on Molecular Allergology (ISMA).

7th Drug hypersensitivity meeting: part two.

Allergen immunotherapy with the hypoallergenic B-cell epitope-based vaccine BM32 modifies IL-10- and IL-5-secreting T cells

Birch pollen allergen-specific immunotherapy with glutaraldehyde-modified allergoid induces IL-10 secretion and protective antibody responses

Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation

Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies

Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.

CD3-positive B cells: a storage-dependent phenomenon

Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.

Cellular in vitro diagnosis of adverse drug reactions

Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris

Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy

Diagnostics of drug hypersensitivity reactions

Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.

IgE and allergen-specific immunotherapy-induced IgG4 recognize similar epitopes of Bet v 1, the major allergen of birch pollen.

Immunoglobulin E and G4 epitopes of the major allergen of birch pollen Bet v 1 share residues critical for antibody binding.

Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects.

Influenza-derived peptides cross-react with allergens and provide asthma protection.

Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.

Monitoring the epitope recognition profiles of IgE, IgG 1 , and IgG 4 during birch pollen immunotherapy

Predominance of IL-5-secreting drug-specific T cells in subgroups of patients with drug-induced delayed-type hypersensitivity reaction

Research Techniques Made Simple: Monitoring of T-Cell Subsets using the ELISPOT Assay.

Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions.

Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner.

Structure of intact IgE and the mechanism of ligelizumab revealed by electron microscopy

T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita

The diversity of Bet v 1–specific IgG 4 antibodies remains mostly constant during the course of birch pollen immunotherapy

The honey bee venom allergen Api m 10 displays one major IgE epitope, Api m 10160-174

Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.